Congress Asset Management Co. Sells 3,852 Shares of Synopsys, Inc. $SNPS

Congress Asset Management Co. trimmed its holdings in shares of Synopsys, Inc. (NASDAQ:SNPS) by 1.4% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 270,012 shares of the semiconductor company’s stock after selling 3,852 shares during the quarter. Congress Asset Management Co. owned about 0.15% of Synopsys worth $133,221,000 at the end of the most recent quarter.

Other institutional investors also recently modified their holdings of the company. CCM Investment Advisers LLC bought a new stake in Synopsys during the 3rd quarter valued at approximately $9,534,000. Bowman & Co S.C. grew its holdings in shares of Synopsys by 21.1% during the 3rd quarter. Bowman & Co S.C. now owns 975 shares of the semiconductor company’s stock worth $481,000 after purchasing an additional 170 shares in the last quarter. Quotient Wealth Partners LLC increased its position in shares of Synopsys by 18.4% during the third quarter. Quotient Wealth Partners LLC now owns 619 shares of the semiconductor company’s stock valued at $305,000 after purchasing an additional 96 shares during the period. Castleview Partners LLC bought a new stake in Synopsys in the 3rd quarter valued at $242,000. Finally, Founders Financial Securities LLC increased its stake in Synopsys by 22.6% in the third quarter. Founders Financial Securities LLC now owns 2,015 shares of the semiconductor company’s stock valued at $994,000 after acquiring an additional 372 shares during the period. Institutional investors own 85.47% of the company’s stock.

Trending Headlines about Synopsys

Here are the key news stories impacting Synopsys this week:

• Positive Sentiment: KeyCorp reiterated bullish coverage and published multi‑year EPS projections and a $600 price target, which supports upside expectations for SNPS and likely helped buying interest. KeyCorp estimates and MarketBeat summary
• Neutral Sentiment: Zacks and other outlets note elevated investor attention in SNPS; increased retail/institutional focus can amplify moves in either direction but does not by itself change fundamentals. Zacks: Investor Attention
• Neutral Sentiment: MarketWatch flagged that SNPS underperformed peers on a relative basis despite daily gains — a reminder that sector rotation and peer performance are constraining factors. MarketWatch: Relative Performance
• Negative Sentiment: Multiple securities‑fraud class‑action notices and law‑firm solicitations have been filed or distributed, alleging material misstatements for purchases made between Dec. 4, 2024 and Sept. 9, 2025; the widely publicized Dec. 30, 2025 lead‑plaintiff deadline increases headline risk and potential legal exposure. GlobeNewswire: Class Action Filed
• Negative Sentiment: Several plaintiff firms (Rosen, Levi & Korsinsky, Faruqi & Faruqi, Bleichmar Fonti & Auld, Schall, Gross, etc.) are soliciting lead‑plaintiff applications — this broad outreach typically precedes contested litigation phases that can drive volatility and potentially settlement costs or reputational damage. Example notice: Rosen Law Firm: Final Deadline Notice

Synopsys Stock Up 1.2%

Shares of NASDAQ:SNPS opened at $463.73 on Friday. The company has a quick ratio of 1.52, a current ratio of 1.62 and a debt-to-equity ratio of 0.48. The firm has a market cap of $86.14 billion, a P/E ratio of 58.04, a P/E/G ratio of 3.86 and a beta of 1.16. Synopsys, Inc. has a 12 month low of $365.74 and a 12 month high of $651.73. The company’s 50-day moving average price is $434.19 and its two-hundred day moving average price is $504.00.

Synopsys (NASDAQ:SNPS) last announced its earnings results on Wednesday, December 10th. The semiconductor company reported $2.90 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.79 by $0.11. Synopsys had a net margin of 18.89% and a return on equity of 7.89%. The company had revenue of $2.25 billion for the quarter, compared to analyst estimates of $2.25 billion. During the same period in the prior year, the business earned $3.40 earnings per share. Synopsys’s quarterly revenue was up 37.8% on a year-over-year basis. Synopsys has set its FY 2026 guidance at 14.320-14.400 EPS and its Q1 2026 guidance at 3.520-3.580 EPS. As a group, research analysts forecast that Synopsys, Inc. will post 10.64 EPS for the current fiscal year.

Analysts Set New Price Targets

Several equities analysts recently commented on SNPS shares. Wall Street Zen upgraded Synopsys from a “sell” rating to a “hold” rating in a research report on Saturday, December 13th. Zacks Research upgraded Synopsys from a “strong sell” rating to a “hold” rating in a research note on Monday, November 10th. Baird R W downgraded shares of Synopsys from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, September 10th. Robert W. Baird reaffirmed a “neutral” rating and issued a $535.00 target price (down previously from $670.00) on shares of Synopsys in a report on Wednesday, September 10th. Finally, Stifel Nicolaus cut their price target on shares of Synopsys from $650.00 to $550.00 and set a “buy” rating for the company in a report on Wednesday, September 10th. Eleven investment analysts have rated the stock with a Buy rating, six have given a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, Synopsys has an average rating of “Moderate Buy” and an average price target of $562.13.

Insider Transactions at Synopsys

In other Synopsys news, CAO Sudhindra Kankanwadi sold 9,873 shares of the stock in a transaction on Monday, September 22nd. The stock was sold at an average price of $500.90, for a total value of $4,945,385.70. Following the transaction, the chief accounting officer directly owned 20,520 shares in the company, valued at approximately $10,278,468. This trade represents a 32.48% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 0.62% of the company’s stock.

Synopsys Company Profile

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.